Kuros Biosciences AG Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	19.77	19.76	16.87	26.03	31.4
Cash & Short-Term Investments	19.77	19.76	16.87	26.03	31.4
Cash Growth	0.03%	17.12%	-35.17%	-17.11%	-2.14%
Accounts Receivable	30.21	14.69	7.61	3.05	1.85
Other Receivables	9.98	3.01	1.43	0.87	0.39
Receivables	40.2	17.7	9.05	3.91	2.25
Inventory	21.35	10.36	5.77	3.43	1.93
Prepaid Expenses	1.35	1.26	0.61	0.58	0.51
Total Current Assets	82.67	49.08	32.29	33.95	36.08
Property, Plant & Equipment	4.68	3.32	3.14	2.51	2.68
Goodwill	24.3	21.31	29.06	31.7	36.63
Other Intangible Assets	16.59	16.44	19.6	20.99	24.8
Long-Term Deferred Tax Assets	5.32	2.56	0.76	0.55	-
Other Long-Term Assets	0.32	-	0.02	-	-
Total Assets	133.88	92.7	84.87	89.7	100.19
Accounts Payable	13.81	7.58	1.55	1.41	0.93
Accrued Expenses	27.18	14.76	9.42	5.44	3.94
Current Portion of Leases	0.65	0.58	0.69	0.45	0.42
Other Current Liabilities	0.5	-	-	6.32	7.09
Total Current Liabilities	42.14	22.92	11.65	13.61	12.38
Long-Term Leases	0.74	1.39	1.86	1.62	2.01
Pension & Post-Retirement Benefits	-	0.15	-	-	0.39
Long-Term Deferred Tax Liabilities	2.94	0.36	-	-	0.98
Other Long-Term Liabilities	3.58	3.46	4.01	-	-
Total Liabilities	49.39	28.28	17.52	15.23	15.75
Common Stock	3.23	3.07	4.37	3.95	3.6
Additional Paid-In Capital	66.87	64.84	87.07	173.2	169.58
Retained Earnings	-37.79	-40.76	-50.06	-125.27	-111.44
Treasury Stock	-	-	-0.02	-0.02	-0.02
Comprehensive Income & Other	52.17	37.27	25.99	22.6	22.72
Shareholders' Equity	84.48	64.42	67.35	74.47	84.44
Total Liabilities & Equity	133.88	92.7	84.87	89.7	100.19
Total Debt	1.39	1.97	2.54	2.07	2.43
Net Cash (Debt)	18.38	17.8	14.33	23.96	28.97
Net Cash Growth	3.28%	24.20%	-40.19%	-17.31%	-1.34%
Net Cash Per Share	0.44	0.48	0.39	0.71	0.88
Filing Date Shares Outstanding	39.15	37.87	36.77	36.54	32.79
Total Common Shares Outstanding	39.15	37.87	36.77	36.54	32.79
Working Capital	40.52	26.16	20.64	20.34	23.7
Book Value Per Share	2.16	1.70	1.83	2.04	2.57
Tangible Book Value	43.59	26.67	18.69	21.77	23.01
Tangible Book Value Per Share	1.11	0.70	0.51	0.60	0.70
Machinery	5.18	2.94	2.08	1.64	1.3
Construction In Progress	0.62	-	-	-	-
Leasehold Improvements	0.1	0.07	0.05	0.05	0.04

Source: S&P Global Market Intelligence. Standard template. Financial Sources.